142 related articles for article (PubMed ID: 9610924)
1. A comparison of the effects of risperidone, raclopride, and ritanserin on intravenous self-administration of d-amphetamine.
Fletcher PJ
Pharmacol Biochem Behav; 1998 May; 60(1):55-60. PubMed ID: 9610924
[TBL] [Abstract][Full Text] [Related]
2. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
[TBL] [Abstract][Full Text] [Related]
3. Depletion of brain serotonin following intra-raphe injections of 5,7-dihydroxytryptamine does not alter d-amphetamine self-administration across different schedule and access conditions.
Fletcher PJ; Korth KM; Chambers JW
Psychopharmacology (Berl); 1999 Sep; 146(2):185-93. PubMed ID: 10525754
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptor antagonists reverse amphetamine-induced behavioral alteration on a differential reinforcement for low-rate (DRL) operant task in the rat.
Cheng RK; Liao RM
Chin J Physiol; 2007 Apr; 50(2):77-88. PubMed ID: 17608145
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of the effects of raclopride on sucrose consumption by the 5-HT2 antagonist ritanserin.
Montgomery AM; Suri A
Psychopharmacology (Berl); 1996 Jan; 123(1):98-102. PubMed ID: 8741960
[TBL] [Abstract][Full Text] [Related]
6. Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin.
Prinssen EP; Kleven MS; Koek W
Psychopharmacology (Berl); 1996 Nov; 128(2):191-7. PubMed ID: 8956380
[TBL] [Abstract][Full Text] [Related]
7. The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex.
Ruiu S; Marchese G; Saba PL; Gessa GL; Pani L
Mol Psychiatry; 2000 Nov; 5(6):673-7. PubMed ID: 11126398
[TBL] [Abstract][Full Text] [Related]
8. Activation of 5-HT(1B) receptors in the nucleus accumbens reduces self-administration of amphetamine on a progressive ratio schedule.
Fletcher PJ; Azampanah A; Korth KM
Pharmacol Biochem Behav; 2002 Apr; 71(4):717-25. PubMed ID: 11888563
[TBL] [Abstract][Full Text] [Related]
9. Time sampling observation procedure for studying drug effects: interaction between d-amphetamine and selective dopamine receptor antagonists in the rat.
Petry N; Furmidge L; Tong ZY; Martin C; Clark D
Pharmacol Biochem Behav; 1993 Jan; 44(1):167-80. PubMed ID: 8430120
[TBL] [Abstract][Full Text] [Related]
10. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
Hertel P; Nomikos GG; Svensson TH
Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
[TBL] [Abstract][Full Text] [Related]
11. A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule.
Izzo E; Orsini C; Koob GF; Pulvirenti L
Pharmacol Biochem Behav; 2001 Apr; 68(4):701-8. PubMed ID: 11526967
[TBL] [Abstract][Full Text] [Related]
12. RU-24969 disrupts d-amphetamine self-administration and responding for conditioned reward via stimulation of 5-HT1B receptors.
Fletcher PJ; Korth KM
Behav Pharmacol; 1999 Mar; 10(2):183-93. PubMed ID: 10780831
[TBL] [Abstract][Full Text] [Related]
13. The serotonin 5-HT(2A) receptor subtype does not mediate apomorphine-induced aggressive behaviour in male Wistar rats.
Skrebuhhova-Malmros T; Pruus K; Rudissaar R; Allikmets L; Matto V
Pharmacol Biochem Behav; 2000 Oct; 67(2):339-43. PubMed ID: 11124399
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.
Wadenberg ML; Salmi P; Jimenez P; Svensson T; Ahlenius S
Eur Neuropsychopharmacol; 1996 Nov; 6(4):305-10. PubMed ID: 8985714
[TBL] [Abstract][Full Text] [Related]
15. Antagonism by the 5-HT2A/C receptor agonist DOI of raclopride-induced catalepsy in the rat.
Wadenberg ML; Ahlenius S
Eur J Pharmacol; 1995 Dec; 294(1):247-51. PubMed ID: 8788438
[TBL] [Abstract][Full Text] [Related]
16. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone.
Nyberg S; Farde L; Eriksson L; Halldin C; Eriksson B
Psychopharmacology (Berl); 1993; 110(3):265-72. PubMed ID: 7530376
[TBL] [Abstract][Full Text] [Related]
17. Intraaccumbens raclopride attenuates amphetamine-induced locomotion, but fails to prevent the response-reinstating properties of food reinforcement.
Chausmer A; Ettenberg A
Pharmacol Biochem Behav; 1999 Feb; 62(2):299-305. PubMed ID: 9972697
[TBL] [Abstract][Full Text] [Related]
18. Effects of the serotonin 5-HT(2) antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats.
Schenk S
Pharmacol Biochem Behav; 2000 Oct; 67(2):363-9. PubMed ID: 11124402
[TBL] [Abstract][Full Text] [Related]
19. Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans.
Rush CR; Stoops WW; Hays LR; Glaser PE; Hays LS
J Pharmacol Exp Ther; 2003 Jul; 306(1):195-204. PubMed ID: 12676890
[TBL] [Abstract][Full Text] [Related]
20. Clozapine blocks D-amphetamine-induced excitation of dopamine neurons in the ventral tegmental area.
Shi WX; Zhang XY; Pun CL; Bunney BS
Neuropsychopharmacology; 2007 Sep; 32(9):1922-8. PubMed ID: 17299514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
